These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 28094079)
1. A Stroke Mimic: Methotrexate-induced Neurotoxicity in the Emergency Department. Rogers P; Pan WJ; Drachtman RA; Haines C J Emerg Med; 2017 Apr; 52(4):559-561. PubMed ID: 28094079 [TBL] [Abstract][Full Text] [Related]
2. Acute methotrexate neurotoxicity: findings on diffusion-weighted imaging and correlation with clinical outcome. Rollins N; Winick N; Bash R; Booth T AJNR Am J Neuroradiol; 2004; 25(10):1688-95. PubMed ID: 15569732 [TBL] [Abstract][Full Text] [Related]
3. Dextromethorphan Administration on Day 0 and Day 7 for Secondary Prevention of Methotrexate-induced Neurotoxicity in Childhood Acute Lymphoblastic Leukemia: A Retrospective Case Series. Fustino NJ; Juhl K; Leister J J Pediatr Hematol Oncol; 2021 Mar; 43(2):e284-e287. PubMed ID: 31929386 [TBL] [Abstract][Full Text] [Related]
4. Methotrexate-induced subacute neurotoxicity in a child with acute lymphoblastic leukemia carrying genetic polymorphisms related to folate homeostasis. Vagace JM; Caceres-Marzal C; Jimenez M; Casado MS; de Murillo SG; Gervasini G Am J Hematol; 2011 Jan; 86(1):98-101. PubMed ID: 21064136 [TBL] [Abstract][Full Text] [Related]
5. Dextromethorphan is effective in the treatment of subacute methotrexate neurotoxicity. Drachtman RA; Cole PD; Golden CB; James SJ; Melnyk S; Aisner J; Kamen BA Pediatr Hematol Oncol; 2002; 19(5):319-27. PubMed ID: 12078863 [TBL] [Abstract][Full Text] [Related]
6. Methotrexate-related neurotoxicity in the treatment of childhood acute lymphoblastic leukemia. Shuper A; Stark B; Kornreich L; Cohen IJ; Avrahami G; Yaniv I Isr Med Assoc J; 2002 Nov; 4(11):1050-3. PubMed ID: 12489505 [TBL] [Abstract][Full Text] [Related]
7. A rare complication of intrathecal methotrexate in a child with acute lymphoblastic leukemia. Tufekci O; Yilmaz S; Karapinar TH; Gozmen S; Cakmakci H; Hiz S; Irken G; Oren H Pediatr Hematol Oncol; 2011 Sep; 28(6):517-22. PubMed ID: 21699468 [TBL] [Abstract][Full Text] [Related]
8. Characteristics of methotrexate-induced stroke-like neurotoxicity. Watanabe K; Arakawa Y; Oguma E; Uehara T; Yanagi M; Oyama C; Ikeda Y; Sasaki K; Isobe K; Mori M; Hanada R; Koh K Int J Hematol; 2018 Dec; 108(6):630-636. PubMed ID: 30182170 [TBL] [Abstract][Full Text] [Related]
10. Ethnic-specific predictors of neurotoxicity among patients with pediatric acute lymphoblastic leukemia after high-dose methotrexate. Harris RD; Bernhardt MB; Zobeck MC; Taylor OA; Gramatges MM; Schafer ES; Lupo PJ; Rabin KR; Scheurer ME; Brown AL Cancer; 2023 Apr; 129(8):1287-1294. PubMed ID: 36692972 [TBL] [Abstract][Full Text] [Related]
11. [Neurotoxicity due to methotrexate in paediatric patients. Description of the clinical symptoms and neuroimaging findings]. Garcia-Puig M; Fons-Estupina MC; Rives-Sola S; Berrueco-Moreno R; Cruz-Martinez O; Campistol J Rev Neurol; 2012 Jun; 54(12):712-8. PubMed ID: 22673947 [TBL] [Abstract][Full Text] [Related]
12. Methotrexate-induced leukoencephalopathy presenting as acute-onset limb weakness in a child: a case report. Pathiraja H; de Abrew G; de Silva L; Fernando S; Randeny S; Mettananda S J Med Case Rep; 2024 Sep; 18(1):475. PubMed ID: 39334488 [TBL] [Abstract][Full Text] [Related]
13. [Neurotoxicity during induction treatment of childhood acute lymphoblastic leukaemia--two case reports]. Kostić G; Jovancić D; Saranac L; Bjelaković B Srp Arh Celok Lek; 2009; 137(5-6):266-70. PubMed ID: 19594068 [TBL] [Abstract][Full Text] [Related]
14. Recurrent intrathecal methotrexate induced neurotoxicity in an adolescent with acute lymphoblastic leukemia: Serial clinical and radiologic findings. Brugnoletti F; Morris EB; Laningham FH; Patay Z; Pauley JL; Pui CH; Jeha S; Inaba H Pediatr Blood Cancer; 2009 Feb; 52(2):293-5. PubMed ID: 18831032 [TBL] [Abstract][Full Text] [Related]
15. [Methotrexate-induced interstitial pneumonitis in a child with acute lymphoblastic leukemia]. Tatsumoto C; Kawakami K; Nagayama J; Kawano H Rinsho Ketsueki; 2004 Oct; 45(10):1100-4. PubMed ID: 15553044 [TBL] [Abstract][Full Text] [Related]
16. Persistent cognitive deficits, induced by intrathecal methotrexate, are associated with elevated CSF concentrations of excitotoxic glutamate analogs and can be reversed by an NMDA antagonist. Vijayanathan V; Gulinello M; Ali N; Cole PD Behav Brain Res; 2011 Dec; 225(2):491-7. PubMed ID: 21856332 [TBL] [Abstract][Full Text] [Related]
17. Alternating hemiparesis and orolingual apraxia as manifestations of methotrexate neurotoxicity in a paediatric case of acute lymphoblastic leukaemia. Yap SM; MacEneaney P; Ryan C; O'Toole O BMJ Case Rep; 2016 Apr; 2016():. PubMed ID: 27113788 [TBL] [Abstract][Full Text] [Related]
18. Intensification with intermediate-dose intravenous methotrexate is effective therapy for children with lower-risk B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group study. Mahoney DH; Shuster JJ; Nitschke R; Lauer S; Steuber CP; Camitta B J Clin Oncol; 2000 Mar; 18(6):1285-94. PubMed ID: 10715299 [TBL] [Abstract][Full Text] [Related]
19. Severe, Fatal Methotrexate-related Neurotoxicity in 2 Adolescent Patients With ALL. Dabagh S; David H; Young S; Doan A; Bhojwani D J Pediatr Hematol Oncol; 2020 Nov; 42(8):e839-e844. PubMed ID: 31876782 [TBL] [Abstract][Full Text] [Related]